Results 251 to 260 of about 75,991 (309)

C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis. [PDF]

open access: yesJ Neurol Neurosurg Psychiatry
Huntemann N   +24 more
europepmc   +1 more source

Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravis. [PDF]

open access: yesTher Adv Neurol Disord
Zhou Y   +12 more
europepmc   +1 more source

Myasthenia gravis and the thymus

open access: bronze, 1962
Alex Harvey, Richard J. Johns
openalex   +1 more source

Efficacy and Safety of Efgartigimod for Patients With Myasthenia Gravis in a Real-World Cohort of 77 Patients. [PDF]

open access: yesCNS Neurosci Ther
Hao S   +12 more
europepmc   +1 more source

Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Stascheit F   +16 more
europepmc   +1 more source

Myasthenia Gravis [PDF]

open access: yesPostgraduate Medical Journal, 1939
openaire   +2 more sources

Efgartigimod Followed by Telitacicept in Adult Generalized Myasthenia Gravis: A Retrospective Case Series. [PDF]

open access: yesJ Inflamm Res
Zhang Y   +11 more
europepmc   +1 more source

Myasthenia gravis

open access: yesThe Journal of Thoracic and Cardiovascular Surgery, 1986
openaire   +2 more sources

Home - About - Disclaimer - Privacy